Shimotai Y, Goto T, Matsuzaki Y, Muraki Y, Sugawara K, Hongo S.: The effect of the cytoplasmic tail of influenza C virus CM2 protein on its biochemical properties and intracellular processing. Biochem Biophys Reports. 3:1–6 (2015)
Murakami K, Yoshino N, Kawamura H, Sasaki Y, Kagabu M, Muraki Y, Sugiyama T.: Tumor suppressive activity of anti-CD274 antibody as an immune checkpoint inhibitor for cervical cancer mouse model. J Reprod Immunol. 112:139 (2015)
Kakisaka M, Sasaki Y (Equal contribution to the first author), Yamada K, Kondoh Y, Hikono H, Osada H, Tomii K, Saito T, Aida Y.: A novel antiviral target structure involved in the RNA binding, dimerization, and nuclear export functions of the influenza A virus nucleoprotein.PLoS Pathogen. 11 (7): e1005062 (2015)
国際学会発表
一般講演
Kagabu M, Murakami K, Kawamura H, Yoshino N, Sugiyama T.: Efficacy of anti-PD-L1 antibody for cervical cancer. International Conference of Cancer Immunotherapy and Macrophages. Jul,2015. Tokyo, Japan
Shimotai Y, Goto T, Matsuzaki Y, Muraki Y, Sugawara K, Hongo S.:Identification of nuclear export signal of influenza C virus NS1 protein(C型インフルエンザウイルスNS1タンパク質の核外移行シグナルの同定).第63回日本ウイルス学会学術集会.2015年11月.福岡.
Goto T, Shimotai Y, Matsuzaki Y, Muraki Y, Sho R, Sugawara K, Hongo S.:The effect of the phosphorylation of the CM2 protein on influenza C virus replication(C型インフルエンザウイルスCM2タンパク質のウイルス増殖への影響).第63回日本ウイルス学会学術集会.2015年11月.福岡.
Sasaki Y, Yoshino N, Sato S, Muraki Y.:Analysis of beta-propiolactone sensitive influenza virus(ベータプロピオラクトン感受性インフルエンザウイルスの解析).第63回日本ウイルス学会学術集会.2015年11月.福岡.